Litigation

Recent Posts

Alabama High Court Again Says Brand-Name Drug Makers Liable In Generic Injury Case
Posted on 18 Aug 2014 by Tom Moylan

MONTGOMERY, Ala. —(Mealey’s) A brand-name drug manufacturer may be liable under Alabama law for fraud or misrepresentation in a drug label used by generic drug makers, the Alabama Supreme Court held Aug. 15 after reconsidering its 2013 decision... Read More

Tags: drugs , Wyeth , Danny Weeks , drug label , et al. v. Danny Weeks , personal injury , product liability , Alabama , Mutual Pharmaceutical Co. v. Bartlett , Litigation , Inc. , Inc. v. Mensing , Pliva , generic drugs , metoclopramide , Reglan , torts

Failure-To-Update Claims For Generic Drugs Not Preempted In New Jersey, Court Says
Posted on 13 Nov 2014 by Tom Moylan

TRENTON, N.J. — (Mealey’s) A New Jersey state appeals court panel on Nov. 12 affirmed a lower court ruling that generic drug manufacturers can be sued for failure to update their labels with warnings added to the labels of the predecessor... Read More

Tags: preemption , Cornett v. Johnson & Johnson , Barr Pharmaceuticals LLC , Watson Laboratories Inc. , Food and Drug Administration , Mutual Pharmaceutical Co. Inc. , product liability , New Jersey , United Research Laboratories Inc. , FDA , In Re: Reglan Litigation , Fulgenzi v. PLIVA , Sixth Circuit , Pliva Inc. , heartburn drug , Litigation , Actavis Elizabeth LLC , Inc. v. Mensing , Pliva , failure to warn , generic drugs , Teva Pharmaceuticals USA Inc. , Fifth Circuit , metoclopramide , Reglan , torts

5th Circuit: Mensing Doesn't Make Brand-Name Defendants Liable For Injuries
Posted on 26 Oct 2012 by Tom Moylan

NEW ORLEANS - (Mealey's) The U.S. Supreme Court's ruling that preempts failure-to-warn claims involving generic drugs does not change Louisiana state law and make manufacturers of brand-name versions liable, a Fifth Circuit U.S. Court of Appeals... Read More

Tags: Julie Demahy v. Schwarz Pharma , preemption , failure-to-warn claims , Wyeth Inc. , Parkinson's disease. , tardive dyskinesia , Actavis Inc. , Mensing , Schwarz Pharma Inc. , Litigation , Inc. v. Mensing , Pliva , generic drugs , Fifth Circuit , Louisiana state law , metoclopramide , Reglan , Julie Demahy , U.S. Supreme Court